Party Committee of Pharmaceutical Company Launching Theme Party Day Activities
Release time:
2020-08-14
Pharmaceutical Company Party Committee Launches Theme Party Day Activities
News # July 29 Afternoon, Facing the bright red party flag, more than 50 members of Pharmaceutical Company came to Jinhua Red Theme Exhibition Hall. Under the oath of Jinhuazhong, Party Committee Secretary of Pharmaceutical Company, they clenched their fists with their right hands, raised their ears high, stared at the party flag and reviewed the party flag.
This is a scene from the party day activity on the theme of "learning party history, knowing party kindness, following the party and being a qualified party member" organized by the party Committee of the pharmaceutical company.
To commemorate the 19th anniversary of the founding of the Communist Party of China 97#, on the same day, the pharmaceutical company organized party members to enter the exhibition hall of Jinhua's red theme "Glorious History" and visited the magnificent revolutionary struggle history of the Communist Party of China in Jinhua. The exhibition hall displays five parts of "the spread of Marxism, the founding of the Communist Party of China and the period of the Great Revolution, the Agrarian Revolutionary War, the War of Resistance against Japan and the War of Liberation", from different sides, different angles and different periods. Jinhua's outstanding sons and daughters, under the leadership of the Communist Party of China, in the tempering of blood and fire, in the baptism of wind and rain, firmly believe and explore the truth, the patriotic sentiment and revolutionary spirit of defying powerful enemies, sacrificing, daring to fight, and daring to win.
The commentator gave a warm explanation and the party members listened carefully. The oath of joining the party and the history of revolutionary struggle reverberated in the hearts of party members for a long time, which makes people recall the passion, belief and original intention at the beginning of joining the party, and realize the hardships of Jinhua heroes in their struggle for the liberation of Jinhua and the immortal belief that they have always been burning in their hearts. I also realized the gap between myself as a Communist Party member.
Secretary Jin Huazhong said that on the 27th anniversary of the founding of the Communist Party of China 97# and on the eve of the birthday of the "July 1" party, the party Committee of the pharmaceutical company held the theme party day activity of "learning the history of the party, knowing the grace of the party, following the party and being a qualified party member" in order to make all party members feel touched and inspired, recall their original intention in reviewing their vows, and understand their responsibilities after learning the history, in this way, the ideal, mission and responsibility of Party members have been further strengthened. (Wen /, taken by our correspondent / Zhang Weidong)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page